• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Renal Diseases  • Renal Diseases, Other  • Articles for Residents  • Alert me on articles by topic  Social Bookmarking   What's this?

The Beaver Dam Eye Study

Ronald Klein, MD, MPH; Michael D. Knudtson, MS; Kristine E. Lee, MS; Barbara E. K. Klein, MD, MPH

Arch Ophthalmol. 2009;127(2):193-199.

Objective  To examine the associations of the serum cystatin C level and chronic kidney disease with the incidence of age-related macular degeneration (AMD) over 15 years.

Methods  In this population-based cohort study of 4926 individuals aged 43 to 86 years at baseline, 3779 participated in 1 or more follow-up examinations. Age-related macular degeneration was determined by grading photographs of the macula. Individuals were defined as having mild or moderate to severe chronic kidney disease based on a value of more than 45 mL/min/1.73 m² to 60 mL/min/1.73 m² or less and 45 mL/min/1.73 m² or less, respectively, according to the Modification of Diet in Renal Disease Study equation.

Results  While controlling for age and other risk factors, the level of serum cystatin C at baseline was associated with the incidence of early AMD (odds ratio per log standard deviation [95% confidence interval], 1.16 [1.01-1.35]) and exudative AMD (1.42 [1.03-1.96]) but not geographic atrophy (0.89 [0.56-1.41]) or progression of AMD (1.02 [0.88-1.18]). Mild chronic kidney disease was associated with the 15-year cumulative incidence of early AMD (odds ratio per log standard deviation, 1.36 [95% confidence interval, 1.00-1.86]) but not the incidence of other AMD end points.

Conclusion  There is a relationship between the level of serum cystatin C and chronic kidney disease with the incidence of AMD. The underlying biological processes remain to be determined.

Author Affiliations: Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Kidney function, albuminuria and age-related macular degeneration in NHANES III
Weiner et al.
Nephrol Dial Transplant 2011;26:3159-3165.
ABSTRACT | FULL TEXT  

Prevalence of Ocular Fundus Pathology in Patients with Chronic Kidney Disease
Grunwald et al.
CJASN 2010;5:867-873.
ABSTRACT | FULL TEXT  

Complement, Age-Related Macular Degeneration and a Vision of the Future
Gehrs et al.
Arch Ophthalmol 2010;128:349-358.
ABSTRACT | FULL TEXT